Mankind

MannKind Corporation, based in Paramus, NJ, is dedicated to the development and commercialization of innovative therapeutic products and devices aimed at improving the lives of individuals with endocrine and orphan lung diseases. With a focus on cutting-edge technology and solutions-driven scientists, the company strives to enable patients to experience a better quality of life.

Their product pipeline includes the inhaleable insulin Afrezza and the V-Go insulin delivery patch, both of which exemplify MannKind's commitment to innovation in medical treatment. The company continues to expand its reach through partnerships and ongoing clinical trials, aiming for significant advancements in inhaled therapeutic solutions.

Generated from the website